GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Incannex Healthcare Ltd (STU:IQI) » Definitions » ROE % Adjusted to Book Value

Incannex Healthcare (STU:IQI) ROE % Adjusted to Book Value : 0.00% (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Incannex Healthcare ROE % Adjusted to Book Value?

Incannex Healthcare's ROE % for the quarter that ended in Mar. 2024 was -146.45%. Incannex Healthcare's PB Ratio for the quarter that ended in Mar. 2024 was N/A. Incannex Healthcare's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was N/A.

Incannex Healthcare ROE % Adjusted to Book Value Historical Data

The historical data trend for Incannex Healthcare's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Incannex Healthcare ROE % Adjusted to Book Value Chart

Incannex Healthcare Annual Data
Trend Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -64.28 -7.27 -8.39

Incannex Healthcare Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 104.46 - - -

Competitive Comparison of Incannex Healthcare's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Incannex Healthcare's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Incannex Healthcare's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Incannex Healthcare's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Incannex Healthcare's ROE % Adjusted to Book Value falls into.


Incannex Healthcare ROE % Adjusted to Book Value Calculation

Incannex Healthcare's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2022 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-67.61% / 8.06
=-8.39%

Incannex Healthcare's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-146.45% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Incannex Healthcare ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Incannex Healthcare's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Incannex Healthcare (STU:IQI) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Incannex Healthcare Ltd (STU:IQI) » Definitions » ROE % Adjusted to Book Value
Comparable Companies
PNXP CYTH BGXX DRRX RMTI QLI CPIX INIS SHWZ TXMD ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ VTRS SZSE:000538 NBIX
Traded in Other Exchanges
IXHL:USA
Address
8 Century Circuit Norwest, Suite 105, Sydney, NSW, AUS, 3000
Website
https://www.incannex.com.au
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products.